Feel Better in 5 is the first daily 5 minute plan that is easy to maintain, easy-to-follow and requires only the smallest amount of willpower.
A new paper has been published suggesting that one can predict which patients suffering from depression will respond to conventional antidepressants by looking at markers of inflammation in their blood.
They found that patients with high degrees of inflammation do NOT respond to conventional anti-depressants.
It highlights what scientific research has been suggesting for many years – that depression itself can be a symptom of biological changes in the body that are driven by inflammation rather than simply changes in brain chemicals. In these cases, addressing the body’s inflammation rather than using a drug to raise serotonin levels would seem to be common sense.
Interestingly, one of the markers used to determine levels of inflammation in this study is the cytokine IL-1β – this cytokine is also elevated in many other chronic conditions such as obesity, type 2 diabetes and metabolic syndrome.
Again, this makes sense, when we understand that chronic unresolved inflammation drives many different diseases.
This is where medicine is right now – an era of personalised medicine but also the growing awareness that the name of a disease tells us nothing about its aetiology (or root cause).
Depression is simply a name given to a collection of symptoms – the name itself tells us nothing about the root cause of the problem.
I was invited to speak to the public about the implications of this study on Breakfast on BBC One.
— Dr Chatterjee
DISCLAIMER: The content in this blog is not intended to constitute or be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or other qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this blog or on this website.